Treatment and diagnosis of alzheimer's disease
AssigneeIntracell, LLC
InventorsBrian J. Balin, J. Todd Abrams, Alan P. Hudson, Judith A. Whittum-Hudson
Life of this patent
Estimating the term…
Abstract
The invention relates to a method of treating Alzheimer's disease in a mammal comprising administering to the mammal an anti-microbial agent having anti-Chlamydia pneumoniae activity. The invention also relates to a method of diagnosing Alzheimer's disease in a mammal comprising measuring the serum anti-Chlamydia pneumoniae antibody titer in a patient suspected of having Alzheimer's disease.
Claims16
A method of treating Alzheimer's disease in a living being comprising administering to the living being a therapeutic amount of an antimicrobial agent, wherein the antimicrobial agent is a macrolide, and further wherein the macrolide is selected from the group consisting of azithromycin, clarithromycin, dirithromycin, erythromycin and troleandomycin.
A method of treating Alzheimer's disease in a living being comprising administering to the living being a therapeutic amount of an anti-microbial agent, wherein the antimicrobial agent is a fluoroquinolone.
A method of treating Alzheimer's disease in a living being comprising administering to the living being a therapeutic amount of an anti-microbial agent, wherein the antimicrobial agent is a sulfonamide.
A method of treating Alzheimer's disease in a living being comprising administering to the living being a therapeutic amount of an anti-microbial agent, wherein the antimicrobial agent comprises both sulfamethoxazole and trimethoprim.
A method of treating Alzheimer's disease in a living being comprising administering to the living being a therapeutic amount of an anti-microbial agent and an anti-inflammatory agent wherein the antimicrobial agent is a macrolide, and further wherein the macrolide is selected from the group consisting of azithromycin, clarithromycin, dirithromycin, erythromycin and troleandomycin.
A method of treating Alzheimer's disease in a living being comprising administering to the living being a therapeutic amount of an anti-microbial agent and an anti-inflammatory agent wherein the antimicrobial agent is a fluoroquinolone.
A method of treating Alzheimer's disease in a living being comprising administering to the living being a therapeutic amount of an anti-microbial agent and an anti-inflammatory agent wherein the antimicrobial agent is a sulfonamide.
A method of treating Alzheimer's disease in a living being comprising administering to the living being a therapeutic amount of an anti-microbial agent and an anti-inflammatory agent wherein the antimicrobial agent comprises both sulfamethoxazole and trimethoprim.
Dependencies are inferred from the claim text.